Company / Operating Income
Progyny Operating Income History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$85.3M
FY2025
5-year range
$23.3M / $85.3M
FY2021-FY2025
Trend
+26.4%
vs FY2024
Sector context
#74 of 151
Health Care
What the data says
At $85M, Progyny's operating income ranks #74 of 151 in the Health Care sector. Operating Income has increased for 3 consecutive years, from $23M in FY2022 to $85M in FY2025.
Based on SEC 10-K filings.
$85M in FY2025 with a 5-year CAGR of +59.2%.
Improved from $62M to $85M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- +54.0%
- 5-Year CAGR
- +59.2%
- 10-Year CAGR
- -
Sector benchmark
#74 of 151 in Health CareTop 49% of 151This company $85.3M Sector average $716.7M
▼
-88.1% below sector average
Key checks
Key Insights
- Progyny's operating income has grown for 3 consecutive years.
- 5-year CAGR of +59.2%, indicating consistent growth.
- In FY2025, operating income increased 26.4% year-over-year.
- Ranks #74 out of 151 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 3.62 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $85.3M | +26.4% |
| FY2024 | $67.5M | +8.5% |
| FY2023 | $62.2M | +166.4% |
| FY2022 | $23.3M | -27.8% |
| FY2021 | $32.3M | +287.4% |
| FY2020 | $8.3M | -13.7% |
| FY2019 | $9.7M | +380.3% |
| FY2018 | -$3.5M | +68.6% |
| FY2017 | -$11.0M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026